.RESEARCH STUDY FEATURE.06 August 2024.
A large randomized measured trial along with cisgender females highlights the obstacles of fidelity to a regular dental preexposure prophylaxis program and displays that twice-yearly treatment of lenacapavir can keep reliable HIV protection degrees over 6 months.